STOCK TITAN

ICON plc to Present at the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ICON plc (NASDAQ: ICLR), a prominent healthcare intelligence and clinical research organization, has announced that its CEO, Dr. Steve Cutler, will present at the Jefferies Global Healthcare Conference. The event will take place on Thursday, June 6, 2024, at 1:30pm ET. The live webcast and any updates regarding this event will be accessible through the Investor section of the company's website under 'Events'. This presentation underscores ICON's ongoing efforts to engage with investors and stakeholders, showcasing its leadership and innovation in the healthcare sector.

Positive
  • ICON plc's CEO, Dr. Steve Cutler, is set to present at a high-profile event, the Jefferies Global Healthcare Conference, indicating strong leadership.
  • The presentation at the conference can enhance visibility and investor confidence.
  • Engagement at such events suggests proactive communication with investors and stakeholders.
  • The company's inclusion in a reputable conference highlights its standing in the healthcare industry.
Negative
  • The announcement lacks specific financial data or clinical milestones, which might be seen as a lack of tangible progress reports.
  • There's no mention of new partnerships, product launches, or significant business developments in the press release.

DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.

Any changes to this event and links to the live webcast will be posted on the Investor section of our website under “Events”.

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 102 locations in 54 countries as at March 31, 2024. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-G

Kate Haven, +1888 381 7923

Vice President Investor Relations

Source: ICON plc

FAQ

When will ICON plc's CEO present at the Jefferies Global Healthcare Conference?

Dr. Steve Cutler, CEO of ICON plc, will present on Thursday, June 6, 2024, at 1:30pm ET.

Where can I watch the live webcast of ICON plc's presentation?

The live webcast will be available on the Investor section of ICON plc's website under 'Events'.

What is the stock symbol for ICON plc?

The stock symbol for ICON plc is ICLR.

What is ICON plc known for?

ICON plc is known for being a world-leading healthcare intelligence and clinical research organization.

Icon Plc

NASDAQ:ICLR

ICLR Rankings

ICLR Latest News

ICLR Stock Data

15.72B
82.56M
0.66%
102.47%
2.12%
Diagnostics & Research
Healthcare
Link
United States of America
Dublin